ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Ishr E Stx 50-i

Ishr E Stx 50-i (EUE)

4,106.25
16.00
(0.39%)
Cerrado 26 Diciembre 10:30AM

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
4,106.25
Postura de Compra
4,092.50
Postura de Venta
4,120.00
Volume Operado de la Acción
2,817
4,100.00 Rango del Día 4,106.75
0.00 Rango de 52 semanas 0.00
Precio Anterior
4,090.25
Precio de Apertura
4,100.00
Última hora de negociación
Volumen promedio (3 m)
-
Volumen financiero
115,497p
Precio Promedio Ponderado
4,100.00

EUE Últimas noticias

iShares II Euro Stoxx50 UCITS Dist£ Net Asset Value(s)

iShares II Euro Stoxx50 UCITS Dist£ 24 December 2024   Funds Date ISIN code Shares in Issue Currency Net Asset Value NAV/per share Base iShares Core EURO STOXX 50 UCITS ETF EUR (Dist...

iShares II Euro Stoxx50 UCITS Dist£ Net Asset Value(s)

iShares II Euro Stoxx50 UCITS Dist£ 23 December 2024   Funds Date ISIN code Shares in Issue Currency Net Asset Value NAV/per share Base iShares Core EURO STOXX 50 UCITS ETF EUR (Dist...

iShares II Euro Stoxx50 UCITS Dist£ Net Asset Value(s)

iShares II Euro Stoxx50 UCITS Dist£ 20 December 2024   Funds Date ISIN code Shares in Issue Currency Net Asset Value NAV/per share Base iShares Core EURO STOXX 50 UCITS ETF EUR (Dist...

iShares II Euro Stoxx50 UCITS Dist£ Net Asset Value(s)

iShares II Euro Stoxx50 UCITS Dist£ 19 December 2024   Funds Date ISIN code Shares in Issue Currency Net Asset Value NAV/per share Base iShares Core EURO STOXX 50 UCITS ETF EUR (Dist...

iShares II Euro Stoxx50 UCITS Dist£ Net Asset Value(s)

iShares II Euro Stoxx50 UCITS Dist£ 18 December 2024   Funds Date ISIN code Shares in Issue Currency Net Asset Value NAV/per share Base iShares Core EURO STOXX 50 UCITS ETF EUR (Dist...

iShares II Euro Stoxx50 UCITS Dist£ Net Asset Value(s)

iShares II Euro Stoxx50 UCITS Dist£ 17 December 2024   Funds Date ISIN code Shares in Issue Currency Net Asset Value NAV/per share Base iShares Core EURO STOXX 50 UCITS ETF EUR (Dist...

iShares II Euro Stoxx50 UCITS Dist£ Net Asset Value(s)

iShares II Euro Stoxx50 UCITS Dist£ 16 December 2024   Funds Date ISIN code Shares in Issue Currency Net Asset Value NAV/per share Base iShares Core EURO STOXX 50 UCITS ETF EUR (Dist...

iShares II Euro Stoxx50 UCITS Dist£ Net Asset Value(s)

iShares II Euro Stoxx50 UCITS Dist£ 13 December 2024   Funds Date ISIN code Shares in Issue Currency Net Asset Value NAV/per share Base iShares Core EURO STOXX 50 UCITS ETF EUR (Dist...

iShares II Euro Stoxx50 UCITS Dist£ Net Asset Value(s)

iShares II Euro Stoxx50 UCITS Dist£ 12 December 2024   Funds Date ISIN code Shares in Issue Currency Net Asset Value NAV/per share Base iShares Core EURO STOXX 50 UCITS ETF EUR (Dist...

iShares II Euro Stoxx50 UCITS Dist£ Net Asset Value(s)

iShares II Euro Stoxx50 UCITS Dist£ 11 December 2024   Funds Date ISIN code Shares in Issue Currency Net Asset Value NAV/per share Base iShares Core EURO STOXX 50 UCITS ETF EUR (Dist...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
INTZIntrusion Inc
US$ 0.9765
(117.00%)
1.01M
EVAXEvaxion Biotech AS
US$ 1.6301
(92.68%)
6.79M
LIDRAEye Inc
US$ 1.92
(50.00%)
1.6M
RVSNRail Vision Ltd
US$ 1.03
(33.14%)
4.18M
CRKNCrown Electrokinetics Corporation
US$ 0.1644
(24.83%)
27.67M
VIRXViracta Therapeutics Inc
US$ 0.193
(-18.57%)
325.35k
XELBXcel Brands Inc
US$ 0.4401
(-15.19%)
35.45k
MITAColiseum Acquisition Corporation
US$ 10.00
(-13.12%)
10.23k
CTCXCarmell Corporation
US$ 0.282
(-12.42%)
144.75k
LKCOLuokung Technology Corporation
US$ 1.63
(-12.37%)
16.83k
CRKNCrown Electrokinetics Corporation
US$ 0.168
(27.56%)
27.5M
OMEXOdyssey Marine Exploration Inc
US$ 0.5929
(23.39%)
9.41M
EVAXEvaxion Biotech AS
US$ 1.63
(92.67%)
6.79M
KITTNauticus Robotics Inc
US$ 2.18
(22.47%)
4.79M
XTIAXTI Aerospace Inc
US$ 0.0404
(1.00%)
4.4M
Jake731 Jake731 27 segundos hace
I guess we'll sit back and let it play out. Do we have a choice ? 
TPTW
EmpressMonk25 EmpressMonk25 43 segundos hace
Patience follows those invested, impatience follows those who want failure...or daytraders which you are not!
HMBL
misterfishman misterfishman 56 segundos hace
True and nice close today.
RDAR
Bjones2 Bjones2 1 minuto hace
No Dilution, No New shares issued, LOL

Shares for the debt came from Artizen Founders holdings. Read the reports
PVSP
Bjones2 Bjones2 1 minuto hace
No Dilution, No New shares issued, LOL

Shares for the debt came from Artizen Founders holdings. Read the reports
PVSP
TMaga TMaga 2 minutos hace
You are correct. Almost three years now. Cozen screwed up the first patent and the first court that looked at the lawsuit threw it out. HCMC appealed. The appeal court said the patent that cozen supposedly fixed looked OK to send it back to court. The appeals court said they would assign it to a dif
HCMC
karlacorn3 karlacorn3 2 minutos hace
Hello RD. Searching for good news :-). Do you if the $500k wire was received? And do you know if the Hong Kong trip took place to release the $100M
K
https://investorshub.advfn.com/uimage/uploads/2024/12/26/pmffpScreenshot_2024-12-26_141957.png
ITUP
manibiotech manibiotech 2 minutos hace
NWBO has no ownership or management stake in advent 
NWBO
OMOLIVES OMOLIVES 3 minutos hace
Yep...and they keep focusing on the incorrect things regarding WSCG Inc:

https://www.otcmarkets.com/filing/html?id=17033449&guid=lKY-kHdxdv3Th3h

Given the debt loads and share structures of everything mentioned here, absolutely no one has paid attention to share structu
HMBL
PROPHET-of-PROFITS PROPHET-of-PROFITS 4 minutos hace
Really strong trading going into end of year. If it is like this now January could be amazing...
RDAR
dinogreeves dinogreeves 4 minutos hace
This will run like FFI*E did a while back.
LILMF
WhenLambo WhenLambo 4 minutos hace
If this was the conclusion, I can’t understand what the point of their statement about amending financials was even for
TPTW
TenKay TenKay 4 minutos hace
so you don’t think the company should tell its common shareholders how much of WSCG they will end up with?

Doesn’t matter anyways because there is little to nothing they could do about it. The commons don’t have voting control (even in aggregate).

Just another way sti
HMBL
BigMoneyChalupa BigMoneyChalupa 5 minutos hace
Beautiful, love it.
ZHUD
Skulls999 Skulls999 5 minutos hace
Also, does anyone use or know how to use Redditt they have been known to help in situation we are in.
If someone can take the lead and post or contact them. I'm not familiar at all. 
MVNT
Lime Time Lime Time 6 minutos hace
A few more days of end of year tax loss remains. Peeps buying now getting in super cheap. I'm sure GS has reloaded. Only thing now is that he doesn't need to disclose when he buys or sells. The sky is the limit here. Can't wait to ring in the new year
GVSI
redspinelpinktopaz redspinelpinktopaz 6 minutos hace
Look what SOUN had done in the last three months, without earnings.
SOUN
Telling you there’s a chance Telling you there’s a chance 7 minutos hace
Thank you!

Invited the shorts? Even better, wait until Poet announces the sales for all the production they just secured. Then again, sales is a mysterious entity around here isn’t it X.

Short away, we can fuel this up even higher than the all time high next month.
LWLG
dstock07734 dstock07734 7 minutos hace
Gary,

What kind of other vaccines are the possibilities? Can you list any?

Cann you see it? One conclusion from the combo trial is that TAMs are the hurdle. Merck had a very generous deal with Daiichi. Did you do some research and find out Daiichi's ADCs are superior t
NWBO
redspinelpinktopaz redspinelpinktopaz 8 minutos hace
And, just what, is the reality?
LWLG
baltimorebullet baltimorebullet 9 minutos hace
I think I'll let Anavex choose the time and place.
AVXL
BullNBear52 BullNBear52 9 minutos hace
‘Go to Hell,’ ‘The Light of Freedom’ and Other Ways to Send Presidential Christmas Messages
Past U.S. presidents have used their holiday messages to inspire the nation to face hard times by coming together. President-elect Donald J. Trump had his own idea.

Dec. 26, 2024
EmpressMonk25 EmpressMonk25 10 minutos hace
Like I said...including yourself! LOL!!
HMBL
dewophile dewophile 10 minutos hace
Correct. Then of course you have to prove PFE infringed the (now valid) patent. But if they can reverse the lower court ruling one major pillar in PFEs defense goes down
PFE
pottsville pottsville 11 minutos hace
From the latest 10k showing it was nothing more than a scam.
The CEO took the share price from$1:50 to .000001. Yet claims to be a successful leader in biometrics.

Additional technological advances have now been made with regard to both the Company’s biometric credit/debit card
SMME

Su Consulta Reciente

Delayed Upgrade Clock